Skip to main content
Premium Trial:

Request an Annual Quote

Vela Dx Zika Assay Receives CE Mark

NEW YORK (GenomeWeb) – Vela Diagnostics announced today that its real-time PCR-based Sentosa Zika virus assay has received CE marking, clearing it for in vitro diagnostic use in Europe.

The Sentosa SA ZIKV PCR test can identify and differentiate 82 different Zika virus strains using plasma, serum, or urine samples with no cross-reactivity with 44 other pathogens. It runs on Vela's automated Sentosa aPCR workflow and can be combined with the company's dengue and chikungunya assays to help clinicians differentiate hemorrhagic fevers.